Skip to content

Zimmer Biomet Holdings

US · ZBH #1040 by market cap Listed 1970
101.10 -0.37 -0.36%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

✦ Quant Ownership Signal how this is computed

Accumulating
  • The number of reporting institutions decreased by 3 in the most recent period (2026/Q4).
  • Total institutional ownership rose 0.4 percentage points.

Ownership vs. money flow

Diverging

Institutions added shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Institutional ownership

Held by institutions
101.20% +0.42pp
Institutions
1,124 -3
As of
2026/Q4 vs. prior period

Holder types

Mutual Fund88.79%
Hedge Fund4.44%
Public Company3.07%
Government Pension Fund2.01%
Private Company1.02%
Sovereign Wealth Fund0.93%
Insurance Company0.33%
Family Office/Trust0.25%
Individual/Insider0.19%

Top holders as of 2026-09-30

Dodge & Cox 12.01% · 22.73M sh
BlackRock 8.25% · 15.61M sh
Vanguard Capital Management, LLC 7.16% · 13.56M sh
Harris Associates L.P. 6.48% · 12.25M sh
Capital Research 5.82% · 11.02M sh
State Street Global Advisors 4.69% · 8.88M sh
Vanguard Portfolio Management, LLC 4.30% · 8.14M sh
Geode Capital Management, LLC 2.85% · 5.39M sh
T. Rowe Price Group, Inc. 2.52% · 4.80M sh
PRIMECAP Management Company 2.01% · 3.80M sh
UBS Asset Management 2.21% · 4.22M sh
Van Eck Associates Corporation 1.83% · 3.46M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 36 buys · 8 sells

NameRoleStake
Ivan Tornos Chairperson & CEO 0.04%
Suketu Upadhyay Former CFO and Executive VP of Finance, Operations & Supply Chain 0.04%
Chad Phipps Senior VP, Chief Legal & Corporate Affairs Officer and Secretary 0.03%
Wilfred van Zuilen Group President of Europe, Middle East & Africa 0.02%
Sang Yi Former President of Asia Pacific 0.01%
Mark Bezjak Former President of Americas 0.01%
Rachel Ellingson Former Senior Vice President & Chief Strategy Officer 0.01%
Lori Winkler Chief Human Resources Officer 0.01%
Brian Hatcher President, Recon, S.E.T., CMFT, Neuro and Biosurgery 0.00%
Betsy Bernard Independent Director 0.00%
Paul Stellato Interim CFO, VP, Controller & Chief Accounting Officer 0.00%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-09-30 Brian Hatcher President, Recon, S.E.T., CMFT, Neuro and Biosurgery Initial Statement of Beneficial 0 --
2026-09-30 Gary Campbell President of Americas Derivative Exercise and Sale -1,412 $88.42
2026-09-30 Gary Campbell President of Americas Derivative Exercise and Retained +2,174 --
2026-09-30 Gary Campbell President of Americas Initial Statement of Beneficial 0 --
2026-09-29 Robert Hagemann Independent Director Other Derivative Acquisition +306 $89.85
2026-09-29 Arthur Higgins Independent Director Other Derivative Acquisition +306 $89.85
2026-09-29 Louis Shapiro Independent Director Other Derivative Acquisition +153 $89.85
2026-09-29 Maria Hilado Independent Director Other Derivative Acquisition +375 $89.85
2026-09-29 Michael Farrell Lead Independent Director Other Derivative Acquisition +417 $89.85
2026-09-29 Devdatt Kurdikar Independent Director Other Derivative Acquisition +173 $89.85
2026-09-29 Sreelakshmi Kolli Independent Director Other Derivative Acquisition +173 $89.85
2026-09-10 Kevin Thornal Former Group President of Global Businesses & Americas Open Market Disposition -5,691 $92.95
2026-09-03 Chad Phipps Senior VP, Chief Legal & Corporate Affairs Officer and Secretary Open Market Disposition -3,000 $98.35
2026-08-02 Chintan Desai President Asia Pacific Region Other Derivative Acquisition +10,168 --
2026-07-31 Kevin Thornal Former Group President of Global Businesses & Americas Derivative Exercise and Sale -4,266 $92.68
2026-07-31 Kevin Thornal Former Group President of Global Businesses & Americas Derivative Exercise and Retained +5,691 --
2026-07-15 Suketu Upadhyay Former CFO and Executive VP of Finance, Operations & Supply Chain Intent to Sell (Form 144) -7,668 $92.86
2026-06-29 Robert Hagemann Independent Director Other Derivative Acquisition +317 $86.65
2026-06-29 Arthur Higgins Independent Director Other Derivative Acquisition +317 $86.65
2026-06-29 Louis Shapiro Independent Director Other Derivative Acquisition +158 $86.65

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Zimmer Biomet Holdings discussion 0 comments

Add a comment